This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geller, B. L.
Right arrow Articles by Iversen, P. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geller, B. L.
Right arrow Articles by Iversen, P. L.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, October 2003, p. 3233-3239, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3233-3239.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

Inhibition of Gene Expression in Escherichia coli by Antisense Phosphorodiamidate Morpholino Oligomers

B. L. Geller,1,2* J. D. Deere,2 D. A. Stein,2 A. D. Kroeker,2 H. M. Moulton,2 and P. L. Iversen2

Oregon State University,1 AVI Biopharma, Inc., Corvallis, Oregon2

Received 26 February 2003/ Returned for modification 24 April 2003/ Accepted 2 July 2003

Antisense phosphorodiamidate morpholino oligomers (PMOs) were tested for the ability to inhibit gene expression in Escherichia coli. PMOs targeted to either a myc-luciferase reporter gene product or 16S rRNA did not inhibit luciferase expression or growth. However, in a strain with defective lipopolysaccharide (lpxA mutant), which has a leaky outer membrane, PMOs targeted to the myc-luciferase or acyl carrier protein (acpP) mRNA significantly inhibited their targets in a dose-dependent response. A significant improvement was made by covalently joining the peptide (KFF)3KC to the end of PMOs. In strains with an intact outer membrane, (KFF)3KC-myc PMO inhibited luciferase expression by 63%. A second (KFF)3KC-PMO conjugate targeted to lacI mRNA induced ß-galactosidase in a dose-dependent response. The end of the PMO to which (KFF)3KC is attached affected the efficiency of target inhibition but in various ways depending on the PMO. Another peptide-lacI PMO conjugate was synthesized with the cationic peptide CRRRQRRKKR and was found not to induce ß-galactosidase. We conclude that the outer membrane of E. coli inhibits entry of PMOs and that (KFF)3KC-PMO conjugates are transported across both membranes and specifically inhibit expression of their genetic targets.


* Corresponding author. Mailing address: Department of Microbiology, Nash Hall 220, Oregon State University, Corvallis, OR 97331-3804. Phone: (541) 737-1845. Fax: (541) 737-0496. E-mail: gellerb{at}orst.edu.


Antimicrobial Agents and Chemotherapy, October 2003, p. 3233-3239, Vol. 47, No. 10
0066-4804/03/$08.00+0     DOI: 10.1128/AAC.47.10.3233-3239.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Mellbye, B. L., Weller, D. D., Hassinger, J. N., Reeves, M. D., Lovejoy, C. E., Iversen, P. L., Geller, B. L. (2009). Cationic phosphorodiamidate morpholino oligomers efficiently prevent growth of Escherichia coli in vitro and in vivo. J Antimicrob Chemother 0: dkp392v1-dkp392 [Abstract] [Full Text]  
  • Mitev, G. M., Mellbye, B. L., Iversen, P. L., Geller, B. L. (2009). Inhibition of Intracellular Growth of Salmonella enterica Serovar Typhimurium in Tissue Culture by Antisense Peptide-Phosphorodiamidate Morpholino Oligomer. Antimicrob. Agents Chemother. 53: 3700-3704 [Abstract] [Full Text]  
  • Woodford, N., Wareham, D. W., on behalf of the UK Antibacterial Antisense Study, (2009). Tackling antibiotic resistance: a dose of common antisense?. J Antimicrob Chemother 63: 225-229 [Abstract] [Full Text]  
  • Mellbye, B. L., Puckett, S. E., Tilley, L. D., Iversen, P. L., Geller, B. L. (2009). Variations in Amino Acid Composition of Antisense Peptide-Phosphorodiamidate Morpholino Oligomer Affect Potency against Escherichia coli In Vitro and In Vivo. Antimicrob. Agents Chemother. 53: 525-530 [Abstract] [Full Text]  
  • Tilley, L. D., Mellbye, B. L., Puckett, S. E., Iversen, Patrick. L., Geller, B. L. (2007). Antisense peptide-phosphorodiamidate morpholino oligomer conjugate: dose-response in mice infected with Escherichia coli. J Antimicrob Chemother 59: 66-73 [Abstract] [Full Text]  
  • Gruegelsiepe, H., Brandt, O., Hartmann, R. K. (2006). Antisense Inhibition of RNase P: MECHANISTIC ASPECTS AND APPLICATION TO LIVE BACTERIA. J. Biol. Chem. 281: 30613-30620 [Abstract] [Full Text]  
  • Tilley, L. D., Hine, O. S., Kellogg, J. A., Hassinger, J. N., Weller, D. D., Iversen, P. L., Geller, B. L. (2006). Gene-Specific Effects of Antisense Phosphorodiamidate Morpholino Oligomer-Peptide Conjugates on Escherichia coli and Salmonella enterica Serovar Typhimurium in Pure Culture and in Tissue Culture.. Antimicrob. Agents Chemother. 50: 2789-2796 [Abstract] [Full Text]  
  • Tan, X.-X., Actor, J. K., Chen, Y. (2005). Peptide Nucleic Acid Antisense Oligomer as a Therapeutic Strategy against Bacterial Infection: Proof of Principle Using Mouse Intraperitoneal Infection. Antimicrob. Agents Chemother. 49: 3203-3207 [Abstract] [Full Text]  
  • Dryselius, R., Nekhotiaeva, N., Good, L. (2005). Antimicrobial synergy between mRNA- and protein-level inhibitors. J Antimicrob Chemother 56: 97-103 [Abstract] [Full Text]  
  • Geller, B. L., Deere, J., Tilley, L., Iversen, P. L. (2005). Antisense phosphorodiamidate morpholino oligomer inhibits viability of Escherichia coli in pure culture and in mouse peritonitis. J Antimicrob Chemother 55: 983-988 [Abstract] [Full Text]  
  • Deere, J., Iversen, P., Geller, B. L. (2005). Antisense Phosphorodiamidate Morpholino Oligomer Length and Target Position Effects on Gene-Specific Inhibition in Escherichia coli. Antimicrob. Agents Chemother. 49: 249-255 [Abstract] [Full Text]